Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ORAI1 | Q96D31 | 3/20 | 0.46 |
| ▸ | ORAI2 | Q96SN7 | 3/20 | 0.46 |
| ▸ | ORAI3 | Q9BRQ5 | 3/20 | 0.46 |
| ▸ | TRPV6 | Q9H1D0 | 3/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | CA5A | P35218 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.46 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 3/20 | 0.36 |
| ▸ | CES1 | P23141 | 3/20 | 0.36 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.36 |
| ▸ | F2 | P00734 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | MGLL | Q99685 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27008267 | 0.94 | TRPV6 (0.41) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL28664851 | 0.84 | TRPV6 (0.44) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL384014 | 0.82 | ORAI1 (0.42) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL20916961 | 0.82 | LMNA (0.54) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL56273 | 0.82 | ORAI1 (0.42) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL651370 | 0.82 | ORAI1 (0.42) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL14645353 | 0.81 | CA1 (0.55) | CA7ENPP2CA14CES2CES1 | |
| SCHEMBL3470948 | 0.80 | TSHR (0.50) | CA4CA6CA5ACA7CA14 | |
| SCHEMBL2352991 | 0.80 | CA2 (0.48) | ORAI1ORAI2ORAI3TRPV6CES2 | |
| SCHEMBL3793010 | 0.80 | KDM4E (0.35) | CA6CA14F2LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 418 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3995586-B1 | GLYCOSYLATED PROTEIN ASSAY REAGENT CONTAINING PROTEASE STABILIZER INCREASING REDOX POTENTIAL OF FERROCYANIDE, METHOD FOR ASSAYING GLYCOSYLATED PROTEIN, METHOD FOR PRESERVING GLYCOSYLATED PROTEIN ASSAY REAGENT, AND METHOD FOR STABILIZING GLYCOSYLATED PROTEIN ASSAY REAGENT | NAGASE DIAGNOSTICS CO LTD (JP) | 2025-11-05 | — | — | EP | claimed |
| EP-3761030-B1 | METHOD FOR STABILIZING PROTEIN CONTAINED IN SAMPLE AND SOLUTION FOR STABILIZING PROTEIN CONTAINED IN SAMPLE | EIKEN CHEMICAL (JP) | 2025-04-30 | — | — | EP | claimed |
| CN-119552819-A | Exosome enrichment method based on boric acid modified capture material | 河北大学 | 2025-03-04 | — | — | CN | claimed |
| US-12215140-B2 | Method of stabilizing protein contained in specimen and solution for stabilizing protein contained in specimen | EIKEN KAGAKU KABUSHIKI KAISHA (JP) | 2025-02-04 | — | — | US | claimed |
| US-12188898-B2 | Non-enzymatic electrochemical sensor for measuring analytes | TERUMO KABUSHIKI KAISHA (JP) | 2025-01-07 | — | — | US | claimed |
| CN-119033953-A | Anticancer nano co-carried medicine compound, its preparing method and use | 广东医科大学 | 2024-11-29 | — | — | CN | claimed |
| CN-118515880-B | Phenylboronic acid cross-linking agent and preparation method and application thereof | 四川大学 | 2024-11-26 | — | — | CN | claimed |
| CN-114805856-B | Injectable pH/ROS dual-response hydrogel and preparation method and application thereof | 天津大学 | 2024-11-22 | — | — | CN | claimed |
| CN-111788484-B | Method for stabilizing protein contained in sample, solution for stabilizing protein contained in sample | 荣研化学株式会社 | 2024-11-19 | — | — | CN | claimed |
| CN-118976121-A | Preparation and application methods of viroid cation-like ruthenium-based nanoparticle | 山东第一医科大学附属眼科医院(山东省眼科医院) | 2024-11-19 | — | — | CN | claimed |
| EP-2155706-A2 | REPAGLINIDE SUBSTANTIALLY FREE OF DIMER IMPURITY | Actavis Group PTC EHF (IS) | 2010-02-24 | — | — | EP | claimed |
| US-7598486-B2 | Sample plate for glycoprotein analysis by MALDI mass spectrometry and preparation method of the same | Kim, Yangsun (US) | 2009-10-06 | — | — | US | claimed |
| EP-2059227-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | Aeris Therapeutics, Inc. (US) | 2009-05-20 | — | — | EP | claimed |
| WO-2009004485-A2 | REPAGLINIDE SUBSTANTIALLY FREE OF DIMER IMPURITY | ACTAVIS GROUP PTC EHF (IS) | 2009-01-08 | — | — | WO | claimed |
| US-20080116367-A1 | SAMPLE PLATE FOR GLYCOPROTEIN ANALYSIS BY MALDI MASS SPECTROMETRY AND PREPARATION METHOD OF THE SAME | Kim, Yangsun (US) | 2008-05-22 | — | — | US | claimed |
| WO-2008039827-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | AERIS THERAPEUTICS, INC. (US) | 2008-04-03 | — | — | WO | claimed |
| EP-1294404-A2 | PRODRUG COMPOUNDS WITH AN OLIGOPEPTIDE HAVING AN ISOLEUCINE RESIDUE | CORIXA CORPORATION (US) | 2003-03-26 | — | — | EP | claimed |
| WO-2001095943-A2 | PRODRUG COMPOUNDS WITH AN OLIGOPEPTIDE HAVING AN ISOLEUCINE RESIDUE | MEDAREX, INC. (US) | 2001-12-20 | — | — | WO | claimed |
| EP-1107982-A1 | REVERSIBLE BORONATE COMPLEXES OF 1,2-$i(CIS)-DIOL CYCLIC-PEPTIDES | Eli Lilly & Company (US) | 2001-06-20 | — | — | EP | claimed |
| WO-2000012540-A1 | REVERSIBLE BORONATE COMPLEXES OF 1,2-CIS-DIOL CYCLIC-PEPTIDES | ELI LILLY AND COMPANY (US) | 2000-03-09 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12188898-B2 | Non-enzymatic electrochemical sensor for measuring analytes | SPR, SRR, BLVRB | ORAI1 2446/4885ORAI2 2680/4885ORAI3 2761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.